Trial intelligence / Profile preview

DCL-101 vs GoLYTELY for Colonoscopy Bowel Preparation

NCT02910440Phase 2Completed

Sponsor
Dark Canyon Labs
Start
Jan 2017
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of DCL-101 in bowel preparation (2 arms), sponsored by Dark Canyon Labs. Primary endpoint: Incidence of Graded Adverse Events. Started Jan 2017; status: completed.

02

Drugs

DCL-101
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT02910440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02910440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call